Promising results for GAT Therapeutics drug in development for pulmonary fibrosis

by Parc Científic de Barcelona

The biotech company GAT Therapeutics is making progress in the development of GTX-11, a new oral drug candidate for the treatment of idiopathic pulmonary fibrosis. Preclinical results show that GTX-11...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream